BioAtla Stock (NASDAQ: BCAB) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 154.00 / 876.67K |
Day Range | - - - |
52 Wk Range | 1.14 - 4.02 |
Market Cap | $79.59M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | 12.19% |
Days to Cover | 4.95 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of BioAtla (NASDAQ:BCAB) through any online brokerage.
Other companies in BioAtla’s space includes: Serina Therapeutics (AMEX:SER), T2 Biosystems (NASDAQ:TTOO), Eagle Pharmaceuticals (NASDAQ:EGRX), Gritstone Bio (NASDAQ:GRTS) and MAIA Biotechnology (AMEX:MAIA).
There is no analysis for BioAtla.
BioAtla has a consensus price target of $13.14.
The stock price for BioAtla (NASDAQ: BCAB) is $1.6542 last updated July 19, 2024 at 6:38 PM EDT.
There are no upcoming dividends for BioAtla.
BioAtla’s Q2 earnings are confirmed for Friday, August 2, 2024.
There is no upcoming split for BioAtla.
BioAtla is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.